Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical diltiazem cream for chronic anal fissure pain
2006-003931-63Phase 3Terminated
- Sponsor
- SLA Pharma
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diltiazem in anal fissure (4 arms), sponsored by SLA Pharma. Primary endpoint: Pain on defecation (daily VAS score). Started Jan 2007; status: terminated.
02
Drugs
diltiazem
03
Conditions
anal fissure
Beyond the preview
Go deeper on 2006-003931-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-003931-63.